from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2138/lppL

LFCtreatmentdescriptionclass of inhibitor

0.154

Amikacinug/mL Amikacintranslation

0.216

Cap5-10ug/mL Capreomycintranslation

0.639

Rox10-50 ug/mL Roxithromycintranslation

0.300

SM2-5 ug/mL Streptomycintranslation

0.100

Tet5-10 ug/mL Tetracyclinetranslation

-1.074

Rif0.2-5ug/mL Rifampicintranscription

-0.662

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.382

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.000

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.862

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.531

Clofazimine10-13 ug/mL Clofaziminerespiration

0.706

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.958

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.728

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.365

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.815

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.658

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.729

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.454

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.326

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.234

KCN5-20 ug/mL Potassium cyaniderespiration

-0.167

NaN30.2-2 mM Sodium aziderespiration

1.235

Nigericin50 uM Nigericinrespiration

-0.864

TRC10-150 ug/mL Triclosanrespiration

-0.931

TRZ10-25 ug/mL Thioridazinerespiration

-1.354

Valinomycin0.5-10 uM Valinomycinrespiration

1.790

ZnSO42 mM ZnSO4respiration

-0.110

menadione6-10 ug/mL Menadionerespiration

-0.561

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.867

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.331

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.023

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.392

NRP_1Non-replicating persistence stage 1dosRassociated

0.650

Amp0.2mg/mL AmpicillincellWall

0.447

Cephalexin20-100 ug/mL CephalexincellWall

0.670

Cerulenin0.32-5 ug/mL CerulenincellWall

0.182

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.196

EMB10-20 ug/mL EthambutolcellWall

0.702

Eta12-40 ug/mL EthionamidecellWall

1.548

INH0.2-0.4 ug/mL IsoniazidcellWall

0.263

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.514

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.554

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.365

BZA0.12 mg/mL BenzamidearomaticAmides

-0.314

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.289

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.344

H2O24 mM hydrogen peroxideDNAdamaging

-0.679

Levo10 ug/mL LevofloxacinDNAdamaging

1.029

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.843

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.383

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.986

UVUV-irradiationDNAdamaging

-1.796

ARP41-4 ug/mL Antitubercular compound ARP4?

0.745

Antimycin12.5-50 ug/mL Antimycin A?

0.765

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.435

PA_110-50 ug/mL Antitubercular compound PA-1?

0.094

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.064

PA8240.2-2 ug/mL PA-824?

-0.424

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.138

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.838

Verapamil50 uM Verapamil?

0.536

mercaptoethanol2 mM 2-Mercaptoethanol?

0.472

methoxatin10-20 ug/mL Methoxatin?